Circular RNAs are a class of RNAs with a covalently closed configuration, and several members of them have been reported to be capable of regulating various biological processes and predicting the outcome of disease. Among them, circular RNA circ-ITCH has been identified to be aberrantly expressed and associated with disease progression in diverse cancers. However, the correlation of circ-ITCH expression with clinicopathological features, as well as the prognosis of cancers, remains inconclusive. Therefore, a meta-analysis was performed to investigate the clinical significance of circ-ITCH in cancers by systematically summarizing all eligible literatures. Up to August 31, 2020, relevant articles were searched in PubMed, Web of Science, Cochrane library, Embase, CNKI, and Wanfang databases. Pooled hazard ratios (HRs) and odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were calculated. A total of 1604 patients from 14 studies were included in this meta-analysis. The results showed that cancer patients with low circ-ITCH expression were more susceptible to develop lymph node metastasis (
OR
=
2.25
, 95% CI: 1.67-3.02,
p
≤
0.01
), larger tumor size (
OR
=
3.01
, 95% CI: 2.01-4.52,
p
≤
0.01
), advanced TNM stage (
OR
=
2.82
, 95% CI: 1.92-4.14,
p
≤
0.01
), and poor overall survival (OS) (
HR
=
2.45
, 95% CI: 2.07–2.90,
p
≤
0.01
, univariate analysis;
HR
=
2.69
, 95% CI: 1.82-3.96,
p
≤
0.01
, multivariate analysis). Thus, low circ-ITCH expression was significantly associated with aggressive clinicopathological features and unfavorable outcome in various cancers. Therefore, circ-ITCH may serve as a molecular therapy target and a prognostic marker in human cancers.